Herceptin (trastuzumab): Herceptin Solvent Vials/20ml co-packaged with Herceptin Powder for Injection 440mg (SIN11028P) – Voluntary recall of batches N3928B04, N3930B03, N3931B03 and N3931B07
Healthcare professional
Industry member
Therapeutic Products
26 June 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
A Dear Healthcare Professional Letter has been issued by Roche Singapore Pte Ltd to update healthcare professionals on the voluntary recall of four batches of Herceptin Solvent Vials/20ml due to the possible presence of glass particulate matter. The Herceptin Solvent Vials are co-packaged with Herceptin Powder for Injection 440mg vials. Healthcare professionals are advised to refer to the letter for further details, including the management of the recall of the product.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.
